San Francisco, California, May 16, 2017: The global market for dermatology devices and therapeutics is expected to gain from the rising global geriatrics population, states TMR Research in a research report. The report is titled, “Dermatology Diagnostic Devices and Therapeutics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025.”
The global market for dermatology diagnostic devices and therapeutics is gaining prominence owing to rising prevalence of various skin disorders and diseases. The growth trail of the market is projected to be decided by the growing pool of geriatric people, persistence of chronic ailments, and patent expiration. Factors such as swelling activities and favorable government initiatives in order to spread awareness about precarious skin disorders.
The fact that is likely to have a substantial impact on the global dermatology diagnostic devices and therapeutics market is the rise in the global geriatric population. As aging skin is comparatively more prone to different skin disorders such as invasive melanoma and skin cancer among others. Therefore, the use of dermatology therapeutics and diagnostic devices by old aged people is anticipated to augment the growth of the global market in the coming years.
High use of cosmetics, changing lifestyles, and rising pollution has also led a rise in the prevalence of psoriasis and acne, thus in turn having a positive effect on the progress of the global dermatology diagnostic devices and therapeutics market. Moreover, mounting expenses on healthcare services and the introduction of improved and advanced dermatology therapeutics and diagnostic devices has further pushed the market towards path of progress.
Region-wise, the global dermatology devices and therapeutics market has been classified into Latin America, North America, Europe, Asia Pacific, the Middle East and Africa, and the Rest of the world. Amongst these, North America is likely to lead the global market owing to enhanced awareness regarding skin disorders and diseases in the region. Exceptional access to healthcare supportive reimbursement policies is further expected to enhance the growth of the market in the coming years. A well-structured health sector is another factor having a constructive influence on the market. Europe will be closely trailing North America and Asia Pacific will be observed as crucial emerging market.
Many top-drawer companies are striving to integrate several technologies used for the development of diagnostic devices into tablets and smartphones in order to improve the diagnostics rate. Some of the leading companies in the market are Michelson Diagnostics Ltd., LEO Pharma A/S, Galderma S.A., Novartis International AG, Cutera, Inc., Astellas Pharma, Inc., Agfa-Gevaert N.V., and Valeant Pharmaceuticals International, Inc.